OptiGroup has entered into an agreement to acquire 100% of the shares in PacsOn Sverige AB from Herenco AB. The transaction is subject to the approval of the Swedish Competition Authority.

PacsOn, with a turnover of 840 million SEK in 2020, is a leading provider of products and supply solutions within packaging and business consumables. PacsOn will become part of OptiGroup's Business Area Packaging and will continue to operate under its current brand.

Vinge’s team consisted of partner Christina Kokko together with Johanna Wiberg, Elsie Nassar and Ellen Åkerdahl Flygt (M&A), Nina Gransäter (Banking and Finance), Christoffer Nordin and Alva Hägglund (Commercial Agreements), Ebba Svenburg (Employment), Mathilda Persson (IT), Agnes Perbo (GDPR) Sofia Bergenstråhle (Intellectual Property), Kristoffer Larson (Real Property), Lina Österberg (Environmental law), Victoria Gunnerek (Competition law), Tove Lövgren Frisk (Compliance) and Ellinor Gyllenhammar (VDR).

 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026